Mid Term Follow up of VEST Device to Enhance Safein Vein Patency: a Multicentric Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 385
- 试验地点
- 3
- 主要终点
- Re-rivascularization
研究概览
简要总结
Purpose - Bypass grafting is the gold standard for severe coronary disease, yet most repeat revascularizations target previously grafted territories. External stenting of saphenous vein grafts, the most frequently used bypass conduit, has been shown to minimize disease markers. This study evaluates clinical outcomes of external stenting in real world routine practice.
Methods - Three centers enrolled a prospective real-world cohort of external- stenting- enhanced CABG patients. All patients received an internal mammary artery graft to the left anterior descending artery and additional arterial and/or venous grafts. One or more venous grafts were externally stented. Choice of conduits, use of cardiopulmonary bypass, and vein harvesting technique were performed according to the routine practice of each surgeon.
All patients were prescribed standard of care medication and were followed via on site visits or phone interviews for major adverse myocardial and cerebral effects.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •CABG with at least one VEST implant
排除标准
- 未提供
结局指标
主要结局
Re-rivascularization
时间窗: Up to 7 years
Number of PCI or re-CABG performed, stratified by target site
MACCE
时间窗: Up to 7 years
Major adverse cardiac and cerebrovascular events
次要结局
未报告次要终点
